17th Annual Anglonordic Life Science Conference 2021
Optimum supports Anglonordic, the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other.
Tag Archive for: Optimum
Doing the Right Right Thing, and Doing it Better: A Life Sciences Primer on ESG
To be credible and investible, ESG is becoming critical to the fund manager’s perspective, as investors shift further to sustainable investment.
BioWorld Article by Mike Ward on Medicxi’s launch of Centessa Pharmaceuticals
Francesco de Rubertis, a co-founder of Medicixi Ventures, has unveiled the next generation of the venture-backed asset-centric biopharma model with the creation of Centessa Pharmaceuticals Ltd. The new company was created by acquiring, in all-share transactions, total control of 10 companies from the Medicxi portfolio. Read more at BioWorld.com
Destiny Pharma’s Call to Arms to Combat AMR
CEO Neil Clark and CSO Dr Bill Love from Europe’s leading anti-infectives biotech company Destiny Pharma, on how the makers and influencers of health policy could fuel a renaissance in drug development…
Final Takeaways: Optimum’s 12th Annual Healthcare Investor Conference 2020
2021: Priorities for European Pharma & What does the investment landscape look like post Covid-19?
